Technology in clinical trials is allowing for a new age of trials that are streamlined, connected and more engaged with the patient; but only if pharma can embrace the changes.
In a year of “merger mania,” researchers suggest the elimination of competition is reducing innovation in the pharmaceutical industry.
Pancreatic cancer is not only aggressive but also deadly. It is expected to be the second leading cause of cancer-related death by 2030. In this article, researchers are revealing new findings that challenge current beliefs about how and why pancreatic cancer is so aggressive.